Constellium awarded contract with TARDEC, the US Army Tank Automotive Research Development and Engineering Center
Amsterdam, September 28, 2016 – Constellium N.V. (NYSE and Euronext: CSTM) announced today that it has been awarded a contract with TARDEC, the US Army Tank Automotive Research Development and Engineering Center supporting the Combat Vehicle Prototype (CVP) platform.
Being awarded this contract helps demonstrate the expertise of Constellium in the defense market and confirms its growing position as a leading partner for aluminium armored vehicle solutions. Under the agreement, Constellium will supply TARDEC with KEIKOR® 2139 for its entire CVP integrated hull capsule. KEIKOR® 2139 was previously selected for the successful CAMEL (Concept for Advanced Military Explosion-mitigating Land) program. KEIKOR® 2139’s best-in-class blast performance combined with its superior armor piercing (AP) capabilities has proven to be the ideal material selection for TARDEC’s next generation prototype fighting vehicle.
Constellium has been a key partner to the defense industry for many years, continuously developing new solutions for armored vehicles and upgrading in-service equipment. “We are proud to see KEIKOR® 2139, our leading solution for integral hull applications, selected over several other considered materials,” said David Meacham, Vice President of Sales Transportation, Industry and Defense at Constellium. “Thanks to a tireless focus on research and innovation, and a strong investment program over the past five years, we have developed the broadest global offering of specialized aluminium alloys for armor applications.”
“Constellium’s KEIKOR® 2139 aluminium alloy met the necessary performance properties and characterized manufacturing process for the performance and packaging requirements that we were looking for in our hull structure,” said Dr. Erik Polsen, TARDEC’s chief engineer for CVP survivability. “What’s more, once we selected the material, we were able to work with Constellium closely to begin the alloy processing quickly, and they were able to cut the originally-quoted delivery time by more than half.”
Constellium will supply TARDEC with KEIKOR® 2139 product from its manufacturing plant in Ravenswood, West Virginia, in the United States.
Download the press release
Hill+Knowlton Strategies (Media & Investors)
Forward Looking Statement
Certain statements contained in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This press release may contain “forward looking statements” with respect to our business, results of operations and financial condition, and our expectations or beliefs concerning future events and conditions. You can identify forward-looking statements because they contain words such as, but not limited to, “believes,” “expects,” “may,” “should,” “approximately,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” likely,” “will,” “would,” “could” and similar expressions (or the negative of these terminologies or expressions). All forward-looking statements involve risks and uncertainties. Many risks and uncertainties are inherent in our industry and markets. Others are more specific to our business and operations. These risks and uncertainties include, but are not limited to, the ability of Constellium and Wise to achieve expected synergies and the timing thereof; the risk that the businesses will not be integrated successfully or such integration may be more difficult, time-consuming or costly than expected; Constellium’s increased levels of indebtedness as a result of the acquisition of Wise Metals, which could limit Constellium’s operating flexibility and opportunities; the potential failure to retain key employees as a result of the acquisition of Wise Metals or during the integration of the business, the loss of customers, suppliers and other business relationships as a result of the acquisition of Wise Metals; disruptions to business operations resulting from the acquisition of Wise Metals; slower or lower than expected growth in the North American market for Body-in-White aluminium rolled products and other risk factors set forth under the heading “Risk Factors” in our Annual Report on Form 20-F, and as described from time to time in subsequent reports filed with the U.S. Securities and Exchange Commission. The occurrence of the events described and the achievement of the expected results depend on many events, some or all of which are not predictable or within our control. Consequently, actual results may differ materially from the forward-looking statements contained in this press release. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by law.